Drug Profile
Ciclosporin topical - Spherium Biomed
Alternative Names: Ciclosporin 5% topical solution; Cyclosporine 5% topical solution; SP 14019; SP14019-F-01Latest Information Update: 17 Sep 2021
Price :
$50
*
At a glance
- Originator Spherium Biomed
- Class Anti-inflammatories; Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Heart failure therapies; Neuroprotectants
- Mechanism of Action Immunosuppressants; Mitochondrial permeability transition pore inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Atopic dermatitis
Highest Development Phases
- Phase II Atopic dermatitis
- No development reported Psoriasis
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for clinical-Phase-Unknown development in Psoriasis in Spain (Topical, Spray)
- 15 Sep 2018 Ciclosporin topical - Spherium Biomed is available for licensing as of 27 Sep 2018. http://www.spheriumbiomed.com/en/why-spherium.html 9249889
- 15 Sep 2018 Safety and efficacy data from a phase II trial in Atopic Dermatitis presented at the Congress of the European Association of Dermatology and Venereology (EADV-2018)